The US Deprescribing Research Network is delighted to announce that our 2022 Annual Network Meeting will be in-person on Wednesday May 11th in Orlando, Florida in conjunction with the American Geriatrics Society’s Annual Meeting.
This meeting will comprise a wide-ranging series of sessions and activities that are focused on:
- Enhancing skills, providing multidisciplinary perspectives, and offering practical guidance on and opportunities for deprescribing research
- Communicating how the network can help you and your research interests
- Building collaborations and community among people interested in deprescribing research and how it can be used to improve care for older adults
Join us as we build a community of researchers and stakeholders that will generate science, address logistical and safety challenges, and develop infrastructure to promote the conduct and dissemination of research on deprescribing
The annual network meeting is open to all who are interested in research on deprescribing for older adults, including early-stage investigators, more experienced investigators, patients, caregivers, health system stakeholders, and policymakers who have a strong interest in advancing scholarship on deprescribing and translating research findings into everyday practice. The meeting is designed to be interactive so all attendees should be prepared to actively participate. Join the network to get updates about the annual meeting and other upcoming events and opportunities.
Please note that the meeting is NOT designed to provide continuing education on how best to perform deprescribing in clinical practice. People interested in learning about these topics will find great CME content during the American Geriatrics Society meeting. Please also see our Resources for Clinicians page.
USDeN 2022 Annual Meeting Agenda (all times Eastern)
Registration and Breakfast
Cynthia Boyd, MD, MPH and Michael Steinman, MD
Co-PIs, US Deprescribing Research Network
Keynote Address: What Can Translational Research Teach Us about Deprescribing?
Sarah N. Hilmer, MBBS, PhD,
Conjoint Professor of Geriatric Pharmacology
Medicine, Northern Clinical School, University of Sydney
Developing the Evidence that Stakeholders Need to Change Deprescribing Practice
Funding Opportunities to Support Deprescribing Research
Lunch with Table-Based Discussion Groups
USDeN-Sponsored Research Showcase Panel
Large Breakout Groups
Updates in Deprescribing Research